vs
太平洋生物科学（ASMB）与NexPoint Real Estate Finance, Inc.（NREF）财务数据对比。点击上方公司名可切换其他公司
NexPoint Real Estate Finance, Inc.的季度营收约是太平洋生物科学的1.0倍（$11.1M vs $10.8M），NexPoint Real Estate Finance, Inc.净利率更高（216.6% vs -85.2%，领先301.9%），太平洋生物科学同比增速更快（57.6% vs -48.8%）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
NexPoint Real Estate Finance, Inc.是一家总部位于美国的商业地产金融企业，主要为多户住宅、写字楼、工业及酒店物业提供结构化融资方案，运营并管理抵押贷款及其他地产相关投资组合，为利益相关方提供经风险调整的稳定回报。
ASMB vs NREF — 直观对比
营收规模更大
NREF
是对方的1.0倍
$10.8M
营收增速更快
ASMB
高出106.4%
-48.8%
净利率更高
NREF
高出301.9%
-85.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $11.1M |
| 净利润 | $-9.2M | $24.0M |
| 毛利率 | — | — |
| 营业利润率 | -100.9% | — |
| 净利率 | -85.2% | 216.6% |
| 营收同比 | 57.6% | -48.8% |
| 净利润同比 | 4.3% | 58.7% |
| 每股收益（稀释后） | $-0.72 | $0.47 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBNREF
| Q4 25 | — | $11.1M | ||
| Q3 25 | $10.8M | $12.5M | ||
| Q2 25 | $9.6M | $12.1M | ||
| Q1 25 | $9.4M | $11.5M | ||
| Q4 24 | $7.4M | $21.7M | ||
| Q3 24 | $6.8M | $12.5M | ||
| Q2 24 | $8.5M | $6.7M | ||
| Q1 24 | $5.8M | $-12.8M |
净利润ASMBNREF
| Q4 25 | — | $24.0M | ||
| Q3 25 | $-9.2M | $50.9M | ||
| Q2 25 | $-10.2M | $22.3M | ||
| Q1 25 | $-8.8M | $26.0M | ||
| Q4 24 | — | $15.2M | ||
| Q3 24 | $-9.6M | $23.3M | ||
| Q2 24 | $-11.2M | $12.1M | ||
| Q1 24 | $-9.1M | $-14.6M |
营业利润率ASMBNREF
| Q4 25 | — | — | ||
| Q3 25 | -100.9% | — | ||
| Q2 25 | -115.2% | — | ||
| Q1 25 | -105.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -160.1% | — | ||
| Q2 24 | -143.0% | — | ||
| Q1 24 | -185.5% | — |
净利率ASMBNREF
| Q4 25 | — | 216.6% | ||
| Q3 25 | -85.2% | 407.0% | ||
| Q2 25 | -105.9% | 184.5% | ||
| Q1 25 | -93.6% | 225.6% | ||
| Q4 24 | — | 69.9% | ||
| Q3 24 | -140.4% | 186.4% | ||
| Q2 24 | -130.7% | 179.7% | ||
| Q1 24 | -156.9% | 114.3% |
每股收益（稀释后）ASMBNREF
| Q4 25 | — | $0.47 | ||
| Q3 25 | $-0.72 | $1.14 | ||
| Q2 25 | $-1.33 | $0.54 | ||
| Q1 25 | $-1.17 | $0.70 | ||
| Q4 24 | — | $0.71 | ||
| Q3 24 | $-1.51 | $0.74 | ||
| Q2 24 | $-1.98 | $0.40 | ||
| Q1 24 | $-1.66 | $-0.83 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | $31.1M |
| 总债务越低越好 | — | $771.2M |
| 股东权益账面价值 | $182.7M | $388.0M |
| 总资产 | $240.0M | $5.3B |
| 负债/权益比越低杠杆越低 | — | 1.99× |
8季度趋势，按日历期对齐
现金及短期投资ASMBNREF
| Q4 25 | — | $31.1M | ||
| Q3 25 | $22.5M | $17.9M | ||
| Q2 25 | $24.0M | $9.1M | ||
| Q1 25 | $23.4M | $19.2M | ||
| Q4 24 | $38.3M | $3.9M | ||
| Q3 24 | $28.5M | $34.7M | ||
| Q2 24 | $19.2M | $4.3M | ||
| Q1 24 | $18.7M | $13.5M |
总债务ASMBNREF
| Q4 25 | — | $771.2M | ||
| Q3 25 | — | $720.9M | ||
| Q2 25 | — | $815.6M | ||
| Q1 25 | — | $831.5M | ||
| Q4 24 | — | $799.3M | ||
| Q3 24 | — | $815.5M | ||
| Q2 24 | — | $861.0M | ||
| Q1 24 | — | $843.3M |
股东权益ASMBNREF
| Q4 25 | — | $388.0M | ||
| Q3 25 | $182.7M | $375.4M | ||
| Q2 25 | $18.1M | $348.2M | ||
| Q1 25 | $27.1M | $343.7M | ||
| Q4 24 | $33.4M | $336.5M | ||
| Q3 24 | $26.0M | $335.8M | ||
| Q2 24 | $34.7M | $327.5M | ||
| Q1 24 | $32.6M | $327.1M |
总资产ASMBNREF
| Q4 25 | — | $5.3B | ||
| Q3 25 | $240.0M | $5.3B | ||
| Q2 25 | $80.8M | $5.4B | ||
| Q1 25 | $99.0M | $5.4B | ||
| Q4 24 | $119.2M | $5.4B | ||
| Q3 24 | $100.3M | $5.7B | ||
| Q2 24 | $115.3M | $6.6B | ||
| Q1 24 | $119.9M | $7.1B |
负债/权益比ASMBNREF
| Q4 25 | — | 1.99× | ||
| Q3 25 | — | 1.92× | ||
| Q2 25 | — | 2.34× | ||
| Q1 25 | — | 2.42× | ||
| Q4 24 | — | 2.38× | ||
| Q3 24 | — | 2.43× | ||
| Q2 24 | — | 2.63× | ||
| Q1 24 | — | 2.58× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $-4.5M |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | — |
| 自由现金流率自由现金流/营收 | -140.7% | — |
| 资本支出强度资本支出/营收 | 0.4% | — |
| 现金转化率经营现金流/净利润 | — | -0.19× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASMBNREF
| Q4 25 | — | $-4.5M | ||
| Q3 25 | $-15.1M | $8.1M | ||
| Q2 25 | $-16.8M | $3.3M | ||
| Q1 25 | $-23.4M | $16.0M | ||
| Q4 24 | $-51.1M | $4.4M | ||
| Q3 24 | $-15.2M | $14.7M | ||
| Q2 24 | $-17.1M | $-7.5M | ||
| Q1 24 | $-18.4M | $17.7M |
自由现金流ASMBNREF
| Q4 25 | — | — | ||
| Q3 25 | $-15.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-51.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-17.1M | — | ||
| Q1 24 | $-18.4M | — |
自由现金流率ASMBNREF
| Q4 25 | — | — | ||
| Q3 25 | -140.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -695.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -200.6% | — | ||
| Q1 24 | -317.7% | — |
资本支出强度ASMBNREF
| Q4 25 | — | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.2% | — |
现金转化率ASMBNREF
| Q4 25 | — | -0.19× | ||
| Q3 25 | — | 0.16× | ||
| Q2 25 | — | 0.15× | ||
| Q1 25 | — | 0.62× | ||
| Q4 24 | — | 0.29× | ||
| Q3 24 | — | 0.63× | ||
| Q2 24 | — | -0.62× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
